Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study. (rhBMP-2)
Hypertension, Diabetes Mellitus, Blood Disease
About this trial
This is an interventional screening trial for Hypertension
Eligibility Criteria
Inclusion Criteria: Patients have good oral hygiene. Systemic healthy individuals ,Age more than18 years. Healed edentulous area for at least 6 months after tooth extraction (delayed implant protocol). Patients have at least two missing teeth in the jaw (canine to 1st molar area) indicated for the dental implant. Exclusion Criteria: Presence of systemic diseases preventing implantation. Previous implantation or augmentation of the same region. The need for additional bone augmentation procedures (such as maxillary sinus augmentation) Partial or total edentulous ridge associated with a severe knife-edge ridge . Acute infection or any pathological lesion a the implant site. Allergy to one of the materials to be used during operation. Pregnancy. Radiation therapy, bisphosphonate drugs , Osteoradionecrosis.
Sites / Locations
- University of BaghdadRecruiting
Arms of the Study
Arm 1
Experimental
control group
group consist of 16 patients with no protein application